Global X China Biotech ETF (02820.HK) Rises 6.19%, NAV at HKD 69.980

Newtimespace News: As of 14:46 on August 7, Global X China Biotech ETF (02820.HK) stood at HKD 74.400, up 6.19%. The ETF opened at HKD 71.000, with the latest net asset value (NAV) at HKD 69.980, a premium of 0.12%, a 52-week high of HKD 84.500, a 52-week low of HKD 56.700, a turnover of approximately HKD 3.2901 million, and assets under management of approximately HKD 644 million.

Global X China Biotech ETF (02820.HK) closely tracks the Solactive China Biotech Index (Net Total Return). The manager of the fund is Mirae Asset Global Investments (Hong Kong) Limited. The Sub-Fund seeks to provide investment returns closely correlated with the performance of the Solactive China Biotech Index (Net Total Return) (the "Related Index") before deduction of fees and expenses.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.